IDEAYA Biosciences, Inc. (IDYA)
32.89
-1.07
(-3.15%)
USD |
NASDAQ |
Oct 29, 16:00
32.85
-0.04
(-0.12%)
After-Hours: 20:00
IDEAYA Biosciences Price to Book Value : 2.644 for Oct. 29, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 2.644 |
| October 28, 2026 | 2.730 |
| October 27, 2026 | 2.693 |
| October 26, 2026 | 2.643 |
| October 23, 2026 | 2.790 |
| October 22, 2026 | 2.904 |
| October 21, 2026 | 2.851 |
| October 20, 2026 | 2.842 |
| October 19, 2026 | 2.718 |
| October 16, 2026 | 2.641 |
| October 15, 2026 | 2.721 |
| October 14, 2026 | 2.722 |
| October 13, 2026 | 2.754 |
| October 12, 2026 | 2.899 |
| October 09, 2026 | 2.903 |
| October 08, 2026 | 2.899 |
| October 07, 2026 | 2.915 |
| October 06, 2026 | 2.945 |
| October 05, 2026 | 3.060 |
| October 02, 2026 | 3.003 |
| October 01, 2026 | 3.039 |
| September 30, 2026 | 3.088 |
| September 29, 2026 | 3.043 |
| September 28, 2026 | 3.072 |
| September 25, 2026 | 2.949 |
| Date | Value |
|---|---|
| September 24, 2026 | 2.953 |
| September 23, 2026 | 3.011 |
| September 22, 2026 | 3.192 |
| September 21, 2026 | 3.124 |
| September 18, 2026 | 3.088 |
| September 17, 2026 | 3.104 |
| September 16, 2026 | 3.033 |
| September 15, 2026 | 3.027 |
| September 14, 2026 | 3.057 |
| September 11, 2026 | 3.022 |
| September 10, 2026 | 3.010 |
| September 09, 2026 | 3.083 |
| September 08, 2026 | 3.122 |
| September 04, 2026 | 3.204 |
| September 03, 2026 | 3.213 |
| September 02, 2026 | 3.229 |
| September 01, 2026 | 3.211 |
| August 31, 2026 | 3.224 |
| August 28, 2026 | 3.224 |
| August 27, 2026 | 3.358 |
| August 26, 2026 | 3.342 |
| August 25, 2026 | 3.415 |
| August 24, 2026 | 3.219 |
| August 21, 2026 | 3.189 |
| August 20, 2026 | 3.144 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ironwood Pharmaceuticals, Inc. | -- |
| Xencor, Inc. | 4.314 |
| BioMarin Pharmaceutical, Inc. | 1.76 |
| MediciNova, Inc. | 1.849 |
| Viking Therapeutics, Inc. | 5.819 |
Price to Book Value Related Metrics
| PS Ratio | 12.61 |
| Price | 32.89 |
| Earnings Yield | -5.91% |
| Market Cap | 3.170B |